Percutaneous cryoablation for inoperable malignant lung tumors: midterm results.
Cryobiology
; 70(1): 60-5, 2015 Feb.
Article
en En
| MEDLINE
| ID: mdl-25541142
ABSTRACT
OBJECTIVE:
To retrospectively analyze the efficacy and short- to mid-term survival rate of cryoablation for malignant lung tumors.METHODS:
Percutaneous CT-guided cryoablation for 45 malignant lung tumors in 26 patients during 41 sessions from 2009 to 2013 were performed. Follow up CT-scan were used to determine local tumor progression. Survival rate, local tumor control rate and associated risk factors were analyzed.RESULTS:
The immediate during and short-term complications with CTCAE grade 2 or upper include pneumothorax (15%), pleural effusion (20%), pulmonary hemorrhage (24%), pneumonitis (15%), hemothorax (15%), hemoptysis (10%), pain (20%), bronchopleural fistula (n=1), and empyema (n=2). Life-threatening bleeding or hemodynamic instability was not observed. There was no procedural-related mortality. Overall survival rate of 1, 2, 3 years are 96%, 88%, 88%. For curative intent, local tumor control (LTC) rate of 1, 2, 3 years are 75%, 72%, 72%.CONCLUSION:
Cryoablation for malignant lung tumors is effective and feasible in local control of tumor growth, with good short- to mid-term survival rate, as an alternative option for inoperable patients.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Criocirugía
/
Neoplasias Pulmonares
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cryobiology
Año:
2015
Tipo del documento:
Article
País de afiliación:
Taiwán